Adagio Medical Holdings ADGM
NASDAQ ADGM
$0.65 +0.02 (+3.03%)
At close: Aug 21, 2026 · 4:00 PM EDT

Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024)

Adagio Medical Holdings (ADGM) posted Cash from Financing Activities of $5.1 million for Q2 2024, down 47.01% sequentially from $9.6 million in Q1 2024.

Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024) Analysis & Trends

Adagio Medical Holdings has reported Cash from Financing Activities for 2 years, with the latest figure at $5.1 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 Adagio Medical Holdings 14.47 Mn 14.47 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 5.07 Mn
Jun 30, 2024 5.07 Mn
Mar 31, 2024 9.57 Mn
Mar 31, 2024 9.57 Mn
Dec 31, 2023 6.58 Mn
Dec 31, 2023 6.58 Mn